LITTLE FALLS, N.J.,
Dec. 18, 2019 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that
its Board of Directors approved an increase in its semi-annual cash
dividend from $0.10 to $0.105 per outstanding share of the Company's
Common Stock. The dividend is payable on January 31, 2020 to shareholders of record at the
close of business on January 17,
2020.
About Cantel Medical:
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, instruments and instrument
reprocessing workflow systems serving the dental industry,
dialysate concentrates, hollow fiber membrane filtration and
separation products. Additionally, we provide technical service for
our products.
For further information, visit www.cantelmedical.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-medical-announces-5-increase-in-semi-annual-dividend-300977041.html
SOURCE Cantel Medical Corp.